New shot could help control high blood pressure
NCT ID NCT07553442
First seen May 02, 2026 · Last updated May 15, 2026 · Updated 3 times
Summary
This study tests a new medicine called ALN-AGT01 RVR in adults with mild to moderate high blood pressure who have already been treated with another drug, zilebesiran. The goal is to see if it safely lowers blood pressure and reduces a protein linked to hypertension. About 93 participants will receive either the study drug or a placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinical Trial Site
RECRUITINGLake Forest, California, 92630, United States
-
Clinical Trial Site
RECRUITINGTampa, Florida, 33602, United States
-
Clinical Trial Site
RECRUITINGSavannah, Georgia, 31401, United States
Conditions
Explore the condition pages connected to this study.